{"id":9684,"date":"2013-10-07T09:24:52","date_gmt":"2013-10-07T13:24:52","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=9684"},"modified":"2013-10-07T09:24:52","modified_gmt":"2013-10-07T13:24:52","slug":"what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684","title":{"rendered":"What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/07\/2013 (wallstreetpr) \u2013 The FDA approval of Duavee, a menopause drug from <b>Pfizer Inc. (NYSE:PFE)<\/b> makes a lot of business sense for this global biopharmaceutical company and its investors.<\/p>\n<p style=\"text-align: justify;\">While there are already other menopause drugs in the market, PFE\u2019s Duavee is a different one; it is devoid of the usual side effects seen in hormone replacement therapies and it is also perfect in hot-flashes reduction. Because of these attributes, the drug is expected to effectively brace the competition and emerge as the market leader in the women health segment.<\/p>\n<p style=\"text-align: justify;\">The FDA approval of Duavee now means that women troubled by moderate to sever menopause effects can now gain some comfort in their lives. And this also opens up business opportunity for the manufacturing company. The drug, according to manufacturers, will also be used for prevention of post menopause osteoporosis rise. This condition has the effect of increasing fracture risk on victims.<\/p>\n<p style=\"text-align: justify;\">This new menopause drug is a combination of conjugated estrogens and bazedoxifene. In this respect, it borrows a formula from PFE\u2019s Premarin menopause drug. Duavee was developed by PFE in conjunction with Ligand Pharmaceuticals.<\/p>\n<p style=\"text-align: justify;\">As a global bio-pharm and research company, PFE\u2019s core developments have been in specialty care like oncology, nutrition, primary care, emerging markets and animal health. The company\u2019s portfolio includes nutritional products, heath care products, small molecule vaccine, animal and human-biologic and medicines. This business has not disappointed PFE and its investors and now with development of a world-standard menopause solution, this stock is worth and investment.<\/p>\n<p style=\"text-align: justify;\">PFE has a market cap of 191.99 billion. Its P\/E ratio is 19.61 and it has a 52-week trading range of $31.15 high against $23.55 low. The stock closed 0.80% up at $29 on Friday.<\/p>\n<p style=\"text-align: justify;\">Equities analysts are recommending the stock for buy because of its expanding market share and also growing reputation for its successful bio-pharm developments and drug-releases which capture both human and animals market.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/07\/2013 (wallstreetpr) \u2013 The FDA approval of Duavee, a menopause drug from Pfizer Inc. (NYSE:PFE) makes a lot of business sense for this [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":9685,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[993,2745],"stock_ticker":[],"class_list":["post-9684","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nysepfe","tag-pfizer-inc-nysepfe","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/07\/2013 (wallstreetpr) \u2013 The FDA approval of Duavee, a menopause drug from Pfizer Inc. (NYSE:PFE) makes a lot of business sense for this [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-10-07T13:24:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/91.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"259\" \/>\n\t<meta property=\"og:image:height\" content=\"194\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Brendan Byrne\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brendan Byrne\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684\"},\"author\":{\"name\":\"Brendan Byrne\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511\"},\"headline\":\"What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval\",\"datePublished\":\"2013-10-07T13:24:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684\"},\"wordCount\":336,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/91.jpg\",\"keywords\":[\"NYSE:PFE\",\"Pfizer Inc (NYSE:PFE)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684\",\"name\":\"What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/91.jpg\",\"datePublished\":\"2013-10-07T13:24:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/91.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/91.jpg\",\"width\":259,\"height\":194},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511\",\"name\":\"Brendan Byrne\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g\",\"caption\":\"Brendan Byrne\"},\"description\":\"While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. You may contact Brendan via his email (brendanbyrne@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/u\/0\/116608759701551457422).\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/brendan-byrne\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684","og_locale":"en_US","og_type":"article","og_title":"What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval - Wall Street PR","og_description":"Boston, MA 10\/07\/2013 (wallstreetpr) \u2013 The FDA approval of Duavee, a menopause drug from Pfizer Inc. (NYSE:PFE) makes a lot of business sense for this [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-10-07T13:24:52+00:00","og_image":[{"width":259,"height":194,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/91.jpg","type":"image\/jpeg"}],"author":"Brendan Byrne","twitter_misc":{"Written by":"Brendan Byrne","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684"},"author":{"name":"Brendan Byrne","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511"},"headline":"What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval","datePublished":"2013-10-07T13:24:52+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684"},"wordCount":336,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/91.jpg","keywords":["NYSE:PFE","Pfizer Inc (NYSE:PFE)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684","url":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684","name":"What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/91.jpg","datePublished":"2013-10-07T13:24:52+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/91.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/91.jpg","width":259,"height":194},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/what-it-means-that-pfizer-inc-s-nysepfe-ambitious-duavee-menopause-drug-now-gets-fda-approval-9684#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"What It Means That Pfizer Inc.\u2019s (NYSE:PFE) Ambitious Duavee Menopause Drug Now Gets FDA Approval"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511","name":"Brendan Byrne","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g","caption":"Brendan Byrne"},"description":"While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. You may contact Brendan via his email (brendanbyrne@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/u\/0\/116608759701551457422).","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/brendan-byrne"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/9684","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=9684"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/9684\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/9685"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=9684"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=9684"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=9684"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=9684"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}